Kennedy-Wilson (KW) Financials

$6.56 +0.03 (+0.38%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$6.56 0.00 (0.00%)

As of 04:27 AM Eastern

Annual Income Statements for Kennedy-Wilson

This table shows Kennedy-Wilson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	14	71	2.80	101	150	224	93	313	65	-342	-77
Consolidated Net Income / (Loss)	90	59	77	138	212	321	108	336	102	-281	-34
Net Income / (Loss) Continuing Operations	90	59	77	138	212	321	108	336	102	-281	-34
Total Pre-Tax Income	123	112	91	122	270	363	151	463	138	-337	-24
Total Operating Income	50	128	145	104	4.30	154	-54	293	117	182	229
Total Gross Profit	228	359	242	286	263	414	193	535	219	233	239
Total Revenue	399	604	690	802	772	749	454	843	540	563	531
Operating Revenue	399	604	690	802	772	749	454	843	540	563	531
Total Cost of Revenue	171	245	448	516	510	335	261	308	321	330	292
Operating Cost of Revenue	171	245	448	516	510	335	261	308	321	330	292
Total Operating Expenses	178	231	97	181	259	260	247	242	102	51	10
Selling, General & Admin Expense	42	44	45	42	51	42	35	33	37	36	39
Depreciation Expense	105	166	198	213	206	188	180	166	173	158	148
Other Operating Expenses / (Income)	80	111	-	-	-	30	32	42	-4.30	-15	-17
Other Special Charges / (Income)	-54	-97	-156	-78	-	-	-	-	-104	-128	-160
Total Other Income / (Expense), net	73	-16	-54	17	266	209	206	170	21	-519	-252
Interest Expense	84	157	192	218	238	215	211	46	193	261	263
Interest & Investment Income	-46	-	-	-	79	-	81	-192	178	-253	6.50
Other Income / (Expense), net	204	141	137	235	425	424	336	408	36	-5.00	4.20
Income Tax Expense	32	53	14	-16	58	41	44	126	36	-55	10
Preferred Stock Dividends Declared	8.10	3.60	2.80	0.00	0.00	2.60	17	17	29	38	44
Net Income / (Loss) Attributable to Noncontrolling Interest	68	-16	71	38	62	94	-2.30	6.00	8.20	22	-0.70
Basic Earnings per Share	$0.14	$0.66	$0.01	$0.83	$1.04	$1.60	$0.66	$2.26	$0.47	($2.46)	($0.56)
Weighted Average Basic Shares Outstanding	89.20M	103.26M	109.09M	119.15M	142.90M	139.73M	139.74M	138.55M	136.90M	138.93M	137.78M
Diluted Earnings per Share	$0.14	$0.66	$0.01	$0.83	$1.04	$1.58	$0.66	$2.24	$0.47	($2.46)	($0.56)
Weighted Average Diluted Shares Outstanding	91.56M	109.55M	109.09M	119.15M	144.75M	141.50M	140.35M	140.13M	138.57M	138.93M	137.78M
Weighted Average Basic & Diluted Shares Outstanding	89.20M	103.26M	109.09M	151.03M	142.98M	142.17M	141.08M	137.87M	137.97M	138.98M	138.01M
Cash Dividends to Common per Share	$0.36	$0.48	$0.56	$0.70	$0.78	$0.85	$0.88	$0.90	$0.96	$0.96	$0.60

This table shows Kennedy-Wilson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	16	23	-41	39	-92	-248	27	-59	-77	33
Consolidated Net Income / (Loss)	24	39	-29	47	-64	-236	38	-48	-67	44
Net Income / (Loss) Continuing Operations	24	39	-29	47	-64	-236	38	-48	-67	44
Total Pre-Tax Income	38	53	-33	58	-84	-278	64	-60	-78	50
Total Operating Income	22	-35	13	12	54	103	16	3.70	23	186
Total Gross Profit	71	-102	63	60	65	46	57	45	59	78
Total Revenue	152	69	122	145	144	152	120	114	128	170
Operating Revenue	152	69	122	145	144	152	120	114	128	170
Total Cost of Revenue	81	171	59	85	79	107	63	69	69	92
Operating Cost of Revenue	81	171	59	85	79	107	63	69	69	92
Total Operating Expenses	49	-67	49	48	11	-57	42	41	35	-108
Selling, General & Admin Expense	9.20	11	8.40	8.70	8.40	10	8.30	9.50	10	11
Depreciation Expense	46	40	39	40	39	40	39	36	37	36
Other Operating Expenses / (Income)	-6.60	-15	1.60	-1.10	-6.00	-9.60	-5.50	-4.50	-5.50	-1.10
Total Other Income / (Expense), net	15	88	-46	46	-138	-381	49	-64	-101	-137
Interest Expense	1.30	191	-0.10	1.70	64	195	-0.30	0.50	67	195
Interest & Investment Income	-57	339	-62	-66	-74	-51	-65	-64	-20	155
Other Income / (Expense), net	74	-61	16	113	0.70	-135	113	0.50	-13	-96
Income Tax Expense	14	14	-3.90	10	-20	-42	27	-12	-11	6.00
Preferred Stock Dividends Declared	7.90	7.90	7.90	8.40	11	11	11	11	11	11
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.70	8.70	4.20	-0.10	17	1.00	-0.10	-0.10	-0.20	-0.30
Basic Earnings per Share	$0.12	$0.17	($0.30)	$0.28	($0.66)	($1.78)	$0.19	($0.43)	($0.56)	$0.24
Weighted Average Basic Shares Outstanding	136.84M	136.90M	137.95M	139.39M	139.39M	138.93M	138.47M	137.59M	137.41M	137.78M
Diluted Earnings per Share	$0.12	$0.18	($0.30)	$0.28	($0.66)	($1.78)	$0.19	($0.43)	($0.56)	$0.24
Weighted Average Diluted Shares Outstanding	137.08M	138.57M	137.95M	139.55M	139.39M	138.93M	138.63M	137.59M	137.41M	137.78M
Weighted Average Basic & Diluted Shares Outstanding	137.79M	137.97M	139.39M	139.39M	139.39M	138.98M	137.53M	137.41M	137.41M	138.01M
Cash Dividends to Common per Share	$0.24	$0.24	$0.24	$0.24	$0.24	$0.24	$0.24	$0.12	$0.12	$0.12

This table details how cash moves in and out of Kennedy-Wilson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	760	-206	154	-534	137	86	391	-440	-86	-126	-96
Net Cash From Operating Activities	98	178	103	73	93	-20	-13	-30	33	49	55
Net Cash From Continuing Operating Activities	98	178	103	73	93	-20	-13	-30	33	49	55
Net Income / (Loss) Continuing Operations	90	59	77	138	212	321	108	336	102	-281	-34
Consolidated Net Income / (Loss)	90	59	77	138	212	321	108	336	102	-281	-34
Depreciation Expense	105	166	198	213	206	188	180	166	173	158	148
Amortization Expense	-10	0.20	3.10	2.50	0.60	6.30	-0.90	25	3.70	6.60	0.80
Non-Cash Adjustments To Reconcile Net Income	-176	-166	-145	-218	-397	-506	-314	-678	-195	239	-70
Changes in Operating Assets and Liabilities, net	90	118	-30	-62	71	-29	15	120	-51	-74	9.50
Net Cash From Investing Activities	-2,473	-1,484	-287	-70	593	182	591	-1,038	-362	-12	414
Net Cash From Continuing Investing Activities	-2,473	-1,484	-287	-70	593	182	591	-1,038	-362	-12	414
Purchase of Property, Plant & Equipment	-1,962	-1,928	-950	-814	-572	-211	-264	-139	-161	-217	-132
Acquisitions	-215	-188	-125	-80	-401	-266	-112	-281	-361	-167	-125
Purchase of Investments	-14	-10	-11	-1.20	-0.80	-191	-29	-1,162	-419	-2.10	-17
Sale of Property, Plant & Equipment	25	623	540	659	1,467	701	828	486	326	384	590
Sale and/or Maturity of Investments	231	256	275	149	88	149	222	141	304	141	138
Other Investing Activities, net	-537	-236	-16	18	-31	0.30	-54	-83	-51	-150	-40
Net Cash From Financing Activities	3,163	1,119	420	-565	-529	-86	-207	632	264	-165	-566
Net Cash From Continuing Financing Activities	3,163	1,119	420	-565	-529	-86	-207	632	264	-165	-566
Repayment of Debt	-865	-923	-744	-1,249	-1,326	-607	-492	-2,397	-785	-632	-931
Repurchase of Common Equity	-8.20	-11	-65	-68	-178	-21	-57	-83	-31	-21	-15
Payment of Dividends	-148	-359	-378	-944	-244	-382	-159	-159	-171	-199	-150
Issuance of Debt	2,146	2,183	1,565	1,648	1,197	614	496	3,264	930	459	531
Issuance of Preferred Equity	-	-	-	0.00	0.00	295	0.00	0.00	297	197	-0.20
Issuance of Common Equity	2,038	230	42	47	23	15	4.50	7.80	25	31	0.50
Effect of Exchange Rate Changes	-29	-20	-82	28	-21	8.90	20	-4.00	-21	2.00	0.00
Cash Interest Paid	99	134	171	207	225	211	210	184	214	252	256
Cash Interest Received	-	-	-	-	-	-	-	-1.20	0.90	24	26
Cash Income Taxes Paid	0.30	3.00	11	16	6.60	21	13	17	20	22	9.20

This table details how cash moves in and out of Kennedy-Wilson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-40	19	-90	38	-56	-17	228	-175	0.60	-150
Net Cash From Operating Activities	17	38	-67	65	-0.40	52	-5.60	37	-5.60	30
Net Cash From Continuing Operating Activities	17	38	-67	65	-0.40	52	-5.60	37	-5.60	30
Net Income / (Loss) Continuing Operations	24	39	-29	47	-64	-236	38	-48	-67	44
Consolidated Net Income / (Loss)	24	39	-29	47	-64	-236	38	-48	-67	44
Depreciation Expense	46	40	39	40	39	40	39	36	37	36
Amortization Expense	-0.60	4.50	1.00	3.60	-5.00	7.00	-0.10	0.40	6.40	-5.90
Non-Cash Adjustments To Reconcile Net Income	-7.50	-94	8.40	-61	64	228	-79	40	33	-64
Changes in Operating Assets and Liabilities, net	-45	48	-87	35	-34	13	-3.10	8.20	-15	19
Net Cash From Investing Activities	117	-2.80	37	-97	39	8.90	245	-71	85	156
Net Cash From Continuing Investing Activities	117	-2.80	37	-97	39	8.90	245	-71	84	156
Purchase of Property, Plant & Equipment	-50	-52	-39	-54	-53	-71	-52	-37	-22	-21
Acquisitions	-64	-34	-50	-44	-27	-47	-28	-31	-28	-38
Sale of Property, Plant & Equipment	145	58	112	62	109	101	328	2.40	127	132
Sale and/or Maturity of Investments	153	46	18	40	32	51	5.80	14	29	89
Other Investing Activities, net	-14	-12	-3.50	-98	-25	-24	-9.50	-12	-13	-5.70
Net Cash From Financing Activities	-153	-43	-61	66	-93	-77	-9.80	-142	-86	-328
Net Cash From Continuing Financing Activities	-153	-43	-61	66	-93	-77	-9.80	-142	-86	-328
Repayment of Debt	-311	-144	-364	-142	-67	-60	-128	-115	-70	-618
Payment of Dividends	-52	-41	-49	-42	-61	-47	-46	-45	-29	-30
Issuance of Debt	207	121	335	51	35	38	173	24	14	320
Issuance of Preferred Equity	-0.70	-	-	-	-	-0.60	-	-	-	-0.20
Issuance of Common Equity	4.60	20	29	1.50	-	0.20	-0.10	0.10	-	0.50
Effect of Exchange Rate Changes	-21	27	1.10	3.60	-1.80	-0.90	-1.20	1.20	7.50	-7.50
Cash Interest Paid	68	50	78	34	65	75	81	39	82	55
Cash Income Taxes Paid	7.80	4.70	8.40	3.00	5.30	5.10	1.10	1.00	4.90	2.20

This table presents Kennedy-Wilson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	6,332	7,596	7,657	7,725	7,382	7,305	7,329	7,877	8,272	7,712	6,961
Total Current Assets	544	537	1,017	499	545	626	1,013	561	480	371	256
Cash & Equivalents	175	183	886	351	488	574	965	525	439	314	218
Accounts Receivable	56	55	44	63	57	52	48	36	41	57	39
Plant, Property, & Equipment, net	0.00	5,798	5,814	6,444	5,703	5,080	4,721	5,060	5,188	4,837	4,290
Total Noncurrent Assets	5,789	1,261	825	782	1,135	1,598	1,596	2,256	2,604	2,504	2,415
Long-Term Investments	492	445	556	519	860	1,327	1,289	1,948	2,238	2,069	2,042
Noncurrent Note & Lease Receivables	-	-	-	-	-	-	107	-	149	247	231
Other Noncurrent Operating Assets	5,296	816	269	263	275	272	199	308	216	188	141
Total Liabilities & Shareholders' Equity	6,332	7,596	7,657	7,725	7,382	7,305	7,329	7,877	8,272	7,712	6,961
Total Liabilities	3,288	4,731	5,314	6,147	5,951	5,585	5,656	6,073	6,261	5,914	5,325
Total Current Liabilities	265	414	423	485	538	538	562	638	674	616	540
Accounts Payable	12	22	11	20	24	20	30	19	16	18	11
Accrued Expenses	253	392	412	466	514	518	532	619	658	598	529
Total Noncurrent Liabilities	3,000	4,316	4,890	5,662	5,413	5,047	5,095	5,435	5,587	5,298	4,785
Long-Term Debt	3,000	4,316	4,890	5,662	5,413	5,047	5,095	5,435	5,587	5,298	4,785
Total Equity & Noncontrolling Interests	3,044	2,865	2,343	1,578	1,431	1,719	1,673	1,804	2,010	1,798	1,636
Total Preferred & Common Equity	901	1,134	1,048	1,366	1,247	1,679	1,645	1,778	1,964	1,755	1,601
Preferred Stock	0.00	0.00	-	-	0.00	295	295	295	593	790	790
Total Common Equity	901	1,134	1,048	1,366	1,247	1,384	1,349	1,482	1,372	965	812
Common Stock	991	1,226	1,231	1,883	1,745	1,755	1,725	1,680	1,680	1,719	1,713
Retained Earnings	-62	-44	-112	-91	-56	46	18	192	122	-349	-494
Accumulated Other Comprehensive Income / (Loss)	-28	-48	-71	-427	-442	-417	-394	-390	-430	-404	-408
Noncontrolling Interest	2,143	1,731	1,295	212	185	41	28	26	46	43	35

This table presents Kennedy-Wilson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	8,085	8,150	8,194	7,910	7,680	7,495	7,444
Total Current Assets	458	391	427	378	584	408	410
Cash & Equivalents	420	349	387	331	542	367	367
Accounts Receivable	38	41	40	47	43	41	43
Plant, Property, & Equipment, net	5,077	5,129	4,982	4,850	4,604	4,605	4,571
Total Noncurrent Assets	2,549	2,631	2,785	2,682	2,492	2,482	2,463
Long-Term Investments	2,130	2,267	2,321	2,233	2,060	2,056	2,053
Noncurrent Note & Lease Receivables	-	-	-	238	250	248	248
Other Noncurrent Operating Assets	419	363	464	212	182	178	162
Total Liabilities & Shareholders' Equity	8,085	8,150	8,194	7,910	7,680	7,495	7,444
Total Liabilities	6,141	6,179	5,993	5,858	5,895	5,785	5,791
Total Current Liabilities	614	593	659	607	578	563	558
Accounts Payable	11	13	16	14	16	12	9.80
Accrued Expenses	603	580	642	593	563	551	548
Total Noncurrent Liabilities	5,527	5,586	5,335	5,251	5,317	5,222	5,233
Long-Term Debt	5,527	5,586	5,335	5,251	5,317	5,222	5,233
Total Equity & Noncontrolling Interests	1,943	1,971	2,201	2,052	1,785	1,710	1,653
Total Preferred & Common Equity	1,926	1,925	2,154	2,009	1,743	1,670	1,614
Preferred Stock	593	593	791	791	790	790	790
Total Common Equity	1,334	1,332	1,364	1,218	953	880	824
Common Stock	1,672	1,703	1,711	1,718	1,707	1,701	1,706
Retained Earnings	133	48	53	-72	-347	-417	-510
Accumulated Other Comprehensive Income / (Loss)	-471	-418	-400	-427	-407	-404	-372
Noncontrolling Interest	17	47	46	44	42	41	39

This table displays calculated financial ratios and metrics derived from Kennedy-Wilson's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	223.80%	51.46%	14.36%	16.14%	-3.67%	-3.09%	-39.35%	85.59%	-35.91%	4.19%	-5.55%
EBITDA Growth	299.65%	25.42%	10.97%	14.69%	14.77%	21.25%	-40.31%	93.79%	-63.07%	3.55%	11.90%
EBIT Growth	269.64%	6.28%	4.83%	20.31%	26.58%	34.45%	-51.21%	148.65%	-78.16%	15.62%	31.60%
NOPAT Growth	186.89%	84.38%	81.61%	-3.28%	-97.15%	3,934.63%	-128.17%	655.18%	-59.52%	47.62%	25.67%
Net Income Growth	548.20%	-34.52%	29.66%	80.39%	53.70%	51.39%	-66.43%	212.06%	-69.71%	-376.15%	88.02%
EPS Growth	166.67%	371.43%	-98.48%	8,200.00%	25.30%	51.92%	-58.23%	239.39%	-79.02%	-623.40%	77.24%
Operating Cash Flow Growth	213.42%	81.65%	-42.26%	-29.06%	27.53%	-120.95%	35.38%	-140.48%	208.58%	48.63%	12.68%
Free Cash Flow Firm Growth	-3,511.97%	76.84%	181.42%	-151.84%	291.11%	-12.49%	-58.97%	-112.89%	-66.15%	595.57%	113.53%
Invested Capital Growth	701.96%	21.36%	-11.63%	9.96%	-13.70%	-11.47%	-7.25%	5.62%	3.22%	-4.20%	-11.72%
Revenue Q/Q Growth	51.96%	2.24%	0.17%	1.74%	-0.32%	-0.17%	-13.24%	46.95%	-36.31%	-14.52%	103.76%
EBITDA Q/Q Growth	-0.09%	24.74%	2.00%	11.06%	-16.35%	68.86%	-18.02%	-5.67%	-47.09%	-24.97%	1,546.12%
EBIT Q/Q Growth	-7.42%	29.94%	5.38%	13.40%	-20.62%	118.95%	-25.94%	-6.61%	-65.95%	-39.48%	263.71%
NOPAT Q/Q Growth	26.71%	170.14%	21.63%	-20.24%	-94.65%	288.06%	-122.85%	477.19%	-64.53%	52.60%	197.19%
Net Income Q/Q Growth	-29.94%	478.43%	28.14%	77.84%	-25.50%	64.58%	14.44%	-27.59%	-4.77%	-4,366.67%	89.24%
EPS Q/Q Growth	-60.00%	3,200.00%	-94.74%	538.46%	-37.72%	135.82%	0.00%	0.00%	-17.54%	-392.00%	78.29%
Operating Cash Flow Q/Q Growth	-26.85%	40.76%	-27.74%	-52.63%	164.49%	48.95%	-186.30%	67.03%	-33.80%	40.11%	-28.53%
Free Cash Flow Firm Q/Q Growth	-35.70%	48.73%	307.89%	-696.22%	-38.64%	17.43%	-27.22%	-177.77%	-54.86%	26.49%	554.02%
Invested Capital Q/Q Growth	30.86%	4.52%	-14.78%	-9.05%	-2.52%	-0.96%	-2.92%	2.87%	0.00%	-0.55%	-6.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	57.12%	59.47%	35.07%	35.63%	34.04%	55.31%	42.42%	63.45%	40.56%	41.36%	44.98%
EBITDA Margin	87.13%	72.16%	70.02%	69.14%	82.38%	103.07%	101.43%	105.91%	61.04%	60.66%	71.87%
Operating Margin	12.47%	21.27%	20.97%	13.02%	0.56%	20.55%	-11.87%	34.77%	21.65%	32.33%	43.02%
EBIT Margin	63.52%	44.58%	40.86%	42.33%	55.62%	77.17%	62.07%	83.16%	28.33%	31.44%	43.81%
Profit (Net Income) Margin	22.60%	9.77%	11.08%	17.21%	27.46%	42.90%	23.74%	39.92%	18.87%	-50.02%	-6.34%
Tax Burden Percent	73.55%	52.49%	84.53%	113.39%	78.53%	88.58%	71.20%	72.72%	73.79%	83.58%	143.40%
Interest Burden Percent	48.38%	41.77%	32.08%	35.86%	62.87%	62.76%	53.73%	66.02%	90.26%	-190.33%	-10.09%
Effective Tax Rate	26.45%	47.51%	15.47%	-13.39%	21.47%	11.42%	28.80%	27.28%	26.21%	0.00%	0.00%
Return on Invested Capital (ROIC)	1.20%	1.13%	1.98%	1.95%	0.06%	2.63%	-0.82%	4.59%	1.78%	2.64%	3.61%
ROIC Less NNEP Spread (ROIC-NNEP)	6.05%	0.85%	0.70%	2.42%	4.77%	7.76%	4.07%	8.84%	2.31%	-11.39%	-3.52%
Return on Net Nonoperating Assets (RNNOA)	3.46%	0.87%	0.95%	5.09%	14.04%	17.76%	7.17%	14.76%	3.56%	-17.42%	-5.57%
Return on Equity (ROE)	4.67%	2.00%	2.94%	7.04%	14.10%	20.38%	6.36%	19.35%	5.34%	-14.78%	-1.96%
Cash Return on Invested Capital (CROIC)	-154.45%	-18.17%	14.33%	-7.54%	14.77%	14.80%	6.71%	-0.87%	-1.39%	6.93%	16.06%
Operating Return on Assets (OROA)	6.23%	3.86%	3.70%	4.41%	5.69%	7.87%	3.85%	9.22%	1.89%	2.21%	3.17%
Return on Assets (ROA)	2.22%	0.85%	1.00%	1.79%	2.81%	4.37%	1.47%	4.42%	1.26%	-3.52%	-0.46%
Return on Common Equity (ROCE)	2.02%	0.69%	1.23%	4.33%	12.24%	17.02%	5.12%	15.76%	4.00%	-9.07%	-1.02%
Return on Equity Simple (ROE_SIMPLE)	10.00%	5.20%	7.30%	10.11%	17.01%	19.13%	6.56%	18.92%	5.19%	-16.03%	-2.10%
Net Operating Profit after Tax (NOPAT)	37	67	122	118	3.38	136	-38	213	86	127	160
NOPAT Margin	9.17%	11.16%	17.73%	14.76%	0.44%	18.20%	-8.45%	25.29%	15.97%	22.63%	30.11%
Net Nonoperating Expense Percent (NNEP)	-4.84%	0.28%	1.29%	-0.48%	-4.71%	-5.13%	-4.88%	-4.25%	-0.53%	14.03%	7.12%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	1.14%	1.79%	2.49%
Cost of Revenue to Revenue	42.88%	40.53%	64.93%	64.37%	65.96%	44.69%	57.58%	36.55%	59.44%	58.64%	55.02%
SG&A Expenses to Revenue	10.56%	7.26%	6.58%	5.26%	6.58%	5.66%	7.62%	3.95%	6.89%	6.35%	7.30%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	44.66%	38.20%	14.09%	22.61%	33.48%	34.76%	54.30%	28.67%	18.91%	9.03%	1.96%
Earnings before Interest and Taxes (EBIT)	253	269	282	339	430	578	282	701	153	177	233
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	347	436	483	554	636	772	461	892	330	341	382
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.73	1.62	1.52	1.37	1.55	1.77	1.53	1.91	1.39	1.67	1.69
Price to Tangible Book Value (P/TBV)	1.73	1.62	1.52	1.37	1.55	1.77	1.53	1.91	1.39	1.67	1.69
Price to Revenue (P/Rev)	3.91	3.04	2.30	2.33	2.51	3.27	4.56	3.36	3.52	2.87	2.58
Price to Earnings (P/E)	112.99	25.81	567.82	18.57	12.92	10.91	22.28	9.04	29.35	0.00	0.00
Dividend Yield	2.31%	3.62%	3.99%	5.68%	5.80%	4.95%	6.03%	4.43%	6.96%	8.28%	6.01%
Earnings Yield	0.89%	3.87%	0.18%	5.39%	7.74%	9.17%	4.49%	11.06%	3.41%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.12	1.11	1.09	1.08	1.13	1.22	1.16	1.28	1.11	1.14	1.13
Enterprise Value to Revenue (EV/Rev)	15.14	12.02	9.17	8.57	8.01	7.92	11.53	7.26	10.09	9.54	8.89
Enterprise Value to EBITDA (EV/EBITDA)	17.38	16.66	13.10	12.39	9.72	7.68	11.36	6.85	16.54	15.72	12.37
Enterprise Value to EBIT (EV/EBIT)	23.84	26.96	22.45	20.24	14.40	10.26	18.57	8.73	35.62	30.33	20.28
Enterprise Value to NOPAT (EV/NOPAT)	165.10	107.64	51.75	58.03	1,832.27	43.50	0.00	28.70	63.18	42.13	29.51
Enterprise Value to Operating Cash Flow (EV/OCF)	61.52	40.71	61.55	94.10	66.45	0.00	0.00	0.00	165.66	109.70	85.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	7.16	0.00	7.06	7.73	16.64	0.00	0.00	16.07	6.63
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.99	1.51	2.09	3.59	3.78	2.94	3.05	3.01	2.78	2.95	2.92
Long-Term Debt to Equity	0.99	1.51	2.09	3.59	3.78	2.94	3.05	3.01	2.78	2.95	2.92
Financial Leverage	0.57	1.02	1.37	2.10	2.94	2.29	1.77	1.67	1.54	1.53	1.58
Leverage Ratio	2.10	2.36	2.93	3.92	5.02	4.66	4.31	4.37	4.23	4.20	4.27
Compound Leverage Factor	1.02	0.98	0.94	1.41	3.16	2.93	2.32	2.89	3.82	-7.99	-0.43
Debt to Total Capital	49.64%	60.10%	67.61%	78.21%	79.09%	74.59%	75.28%	75.08%	73.54%	74.66%	74.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	49.64%	60.10%	67.61%	78.21%	79.09%	74.59%	75.28%	75.08%	73.54%	74.66%	74.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	4.36%	4.36%	4.08%	7.80%	11.13%	12.30%
Noncontrolling Interests to Total Capital	35.45%	24.11%	17.90%	2.93%	2.70%	0.60%	0.42%	0.36%	0.61%	0.61%	0.54%
Common Equity to Total Capital	14.91%	15.79%	14.49%	18.86%	18.22%	20.45%	19.94%	20.48%	18.05%	13.60%	12.64%
Debt to EBITDA	8.64	9.91	10.12	10.21	8.51	6.54	11.06	6.09	16.95	15.52	12.53
Net Debt to EBITDA	6.72	8.47	7.13	8.64	6.39	4.08	6.17	3.32	8.83	8.54	6.61
Long-Term Debt to EBITDA	8.64	9.91	10.12	10.21	8.51	6.54	11.06	6.09	16.95	15.52	12.53
Debt to NOPAT	82.07	64.04	39.95	47.83	1,603.01	37.05	-132.75	25.51	64.77	41.61	29.90
Net Debt to NOPAT	63.83	54.73	28.18	40.47	1,203.83	23.10	-74.00	13.90	33.73	22.89	15.78
Long-Term Debt to NOPAT	82.07	64.04	39.95	47.83	1,603.01	37.05	-132.75	25.51	64.77	41.61	29.90
Altman Z-Score	0.52	0.44	0.46	0.42	0.48	0.65	0.49	0.70	0.30	0.21	0.19
Noncontrolling Interest Sharing Ratio	56.78%	65.56%	58.11%	38.44%	13.18%	16.51%	19.43%	18.55%	25.18%	38.65%	48.27%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.05	1.30	2.40	1.03	1.01	1.16	1.80	0.88	0.71	0.60	0.47
Quick Ratio	2.05	1.30	2.40	1.03	1.01	1.16	1.80	0.88	0.71	0.60	0.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,690	-1,086	884	-458	876	767	315	-41	-67	334	713
Operating Cash Flow to CapEx	5.06%	13.66%	25.13%	47.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-55.57	-6.93	4.62	-2.11	3.68	3.56	1.49	-0.89	-0.35	1.28	2.71
Operating Cash Flow to Interest Expense	1.16	1.14	0.54	0.34	0.39	-0.09	-0.06	-0.66	0.17	0.19	0.21
Operating Cash Flow Less CapEx to Interest Expense	-21.79	-7.19	-1.60	-0.38	4.15	2.19	2.61	6.93	1.02	0.83	1.95
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.10	0.09	0.09	0.10	0.10	0.10	0.06	0.11	0.07	0.07	0.07
Accounts Receivable Turnover	11.04	10.95	13.99	15.03	12.95	13.77	9.08	20.06	14.04	11.47	11.07
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.12	0.13	0.13	0.14	0.09	0.17	0.11	0.11	0.12
Accounts Payable Turnover	2.43	14.44	26.84	33.62	23.37	15.03	10.35	12.65	18.45	19.35	20.38
Days Sales Outstanding (DSO)	33.06	33.34	26.09	24.29	28.19	26.50	40.20	18.19	25.99	31.82	32.97
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	150.36	25.28	13.60	10.86	15.62	24.28	35.26	28.86	19.79	18.86	17.91
Cash Conversion Cycle (CCC)	-117.30	8.06	12.49	13.43	12.57	2.22	4.94	-10.66	6.20	12.96	15.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,400	6,554	5,792	6,369	5,496	4,866	4,513	4,766	4,920	4,714	4,161
Invested Capital Turnover	0.13	0.10	0.11	0.13	0.13	0.14	0.10	0.18	0.11	0.12	0.12
Increase / (Decrease) in Invested Capital	4,727	1,154	-762	577	-873	-630	-353	254	154	-206	-553
Enterprise Value (EV)	6,035	7,255	6,334	6,869	6,187	5,927	5,233	6,116	5,450	5,364	4,722
Market Capitalization	1,559	1,835	1,590	1,866	1,938	2,445	2,070	2,832	1,902	1,616	1,373
Book Value per Share	$9.50	$9.90	$9.25	$9.02	$8.65	$9.71	$9.52	$10.64	$9.95	$6.92	$5.91
Tangible Book Value per Share	$9.50	$9.90	$9.25	$9.02	$8.65	$9.71	$9.52	$10.64	$9.95	$6.92	$5.91
Total Capital	6,044	7,181	7,233	7,239	6,844	6,766	6,767	7,239	7,597	7,096	6,421
Total Debt	3,000	4,316	4,890	5,662	5,413	5,047	5,095	5,435	5,587	5,298	4,785
Total Long-Term Debt	3,000	4,316	4,890	5,662	5,413	5,047	5,095	5,435	5,587	5,298	4,785
Net Debt	2,333	3,689	3,449	4,791	4,065	3,147	2,840	2,963	2,910	2,915	2,525
Capital Expenditures (CapEx)	1,938	1,305	410	155	-895	-490	-564	-347	-165	-167	-458
Debt-free, Cash-free Net Working Capital (DFCFNWC)	104	-60	-292	-338	-481	-486	-514	-602	-634	-558	-502
Debt-free Net Working Capital (DFNWC)	279	123	594	13	6.80	88	451	-77	-194	-245	-284
Net Working Capital (NWC)	279	123	594	13	6.80	88	451	-77	-194	-245	-284
Net Nonoperating Expense (NNE)	-54	8.40	46	-20	-209	-185	-146	-123	-16	409	194
Net Nonoperating Obligations (NNO)	2,357	3,689	3,449	4,791	4,065	3,147	2,840	2,963	2,910	2,915	2,525
Total Depreciation and Amortization (D&A)	94	167	201	215	207	194	179	192	177	164	149
Debt-free, Cash-free Net Working Capital to Revenue	26.12%	-9.91%	-42.24%	-42.16%	-62.30%	-64.97%	-113.19%	-71.40%	-117.33%	-99.25%	-94.37%
Debt-free Net Working Capital to Revenue	69.92%	20.34%	86.05%	1.66%	0.88%	11.70%	99.38%	-9.11%	-35.98%	-43.49%	-53.44%
Net Working Capital to Revenue	69.92%	20.34%	86.05%	1.66%	0.88%	11.70%	99.38%	-9.11%	-35.98%	-43.49%	-53.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	$0.66	$0.01	$0.00	$1.04	$1.60	$0.66	$2.26	$0.47	($2.46)	($0.56)
Adjusted Weighted Average Basic Shares Outstanding	89.20M	103.26M	109.09M	0.00	142.90M	139.73M	139.74M	138.55M	136.90M	138.93M	137.78M
Adjusted Diluted Earnings per Share	$0.14	$0.66	$0.01	$0.00	$1.04	$1.58	$0.66	$2.24	$0.47	($2.46)	($0.56)
Adjusted Weighted Average Diluted Shares Outstanding	91.56M	109.55M	109.09M	0.00	144.75M	141.50M	140.35M	140.13M	138.57M	138.93M	137.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	96.01M	114.41M	114.90M	0.00	142.98M	142.17M	141.08M	137.87M	137.97M	138.98M	138.01M
Normalized Net Operating Profit after Tax (NOPAT)	-3.31	16	-1.27	22	4.71	136	-38	213	9.74	38	48
Normalized NOPAT Margin	-0.83%	2.70%	-0.18%	2.71%	0.61%	18.20%	-8.45%	25.29%	1.80%	6.76%	9.02%
Pre Tax Income Margin	30.73%	18.62%	13.11%	15.18%	34.97%	48.43%	33.35%	54.90%	25.57%	-59.85%	-4.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.00	1.72	1.47	1.56	1.80	2.69	1.33	15.33	0.79	0.68	0.89
NOPAT to Interest Expense	0.43	0.43	0.64	0.54	0.01	0.63	-0.18	4.66	0.45	0.49	0.61
EBIT Less CapEx to Interest Expense	-19.96	-6.61	-0.66	0.85	5.56	4.96	4.00	22.93	1.65	1.32	2.63
NOPAT Less CapEx to Interest Expense	-22.52	-7.90	-1.50	-0.17	3.77	2.91	2.49	12.26	1.30	1.13	2.35
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	163.82%	609.15%	494.51%	684.13%	115.23%	118.81%	147.12%	47.38%	168.11%	-70.79%	-445.70%
Augmented Payout Ratio	172.92%	628.47%	579.22%	733.19%	199.10%	125.26%	200.37%	72.12%	198.72%	-78.22%	-490.21%

This table displays calculated financial ratios and metrics derived from Kennedy-Wilson's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-41.01%	-81.61%	-20.01%	-13.01%	-5.33%	119.31%	-1.23%	-21.50%	-11.34%	11.70%
EBITDA Growth	-25.22%	-120.89%	-50.95%	75.68%	-37.62%	127.81%	139.43%	-75.74%	-39.57%	751.06%
EBIT Growth	-35.38%	-147.49%	-70.01%	132.90%	-43.27%	66.04%	335.14%	-96.65%	-81.62%	377.16%
NOPAT Growth	-85.07%	-120.26%	-87.58%	-63.24%	169.05%	380.66%	-2.64%	-73.72%	-56.98%	127.52%
Net Income Growth	-67.45%	-11.51%	-171.75%	5,355.56%	-371.61%	-701.79%	231.36%	-202.11%	-4.21%	118.52%
EPS Growth	-74.47%	-35.71%	-225.00%	500.00%	-650.00%	-1,088.89%	163.33%	-253.57%	15.15%	113.48%
Operating Cash Flow Growth	191.30%	-30.88%	-13.75%	72.99%	-102.38%	37.23%	91.64%	-43.28%	-1,300.00%	-42.64%
Free Cash Flow Firm Growth	-350.68%	-41.05%	77.35%	134.36%	179.93%	255.30%	638.52%	30.03%	32.93%	157.34%
Invested Capital Growth	6.19%	3.22%	1.91%	-4.67%	-3.67%	-4.20%	-8.91%	-6.59%	-5.77%	-11.72%
Revenue Q/Q Growth	-8.93%	-54.31%	-50.97%	19.42%	-0.90%	5.84%	249.63%	-5.08%	11.94%	33.33%
EBITDA Q/Q Growth	46.99%	-135.86%	-45.18%	141.43%	-47.81%	-84.01%	201.76%	-75.54%	30.00%	125.14%
EBIT Q/Q Growth	78.25%	-199.48%	-64.34%	323.31%	-56.58%	-159.56%	160.98%	-96.74%	138.10%	798.00%
NOPAT Q/Q Growth	-47.89%	-283.52%	-68.43%	5.06%	281.46%	91.43%	107.64%	-71.64%	524.32%	912.50%
Net Income Q/Q Growth	2,722.22%	66.10%	-173.21%	264.81%	-235.52%	-268.02%	115.98%	-228.12%	-38.30%	165.42%
EPS Q/Q Growth	271.43%	50.00%	-266.67%	193.33%	-335.71%	-169.70%	110.67%	-326.32%	-30.23%	142.86%
Operating Cash Flow Q/Q Growth	-55.08%	123.81%	-278.19%	196.57%	-100.62%	13,000.00%	-110.85%	755.36%	-115.26%	628.57%
Free Cash Flow Firm Q/Q Growth	61.99%	34.28%	32.66%	395.56%	-11.59%	27.69%	416.89%	-28.64%	-9.61%	147.20%
Invested Capital Q/Q Growth	-2.85%	0.00%	0.42%	-2.29%	-1.82%	-0.55%	-4.52%	0.20%	-0.96%	-6.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.68%	-146.97%	51.69%	41.14%	44.85%	30.03%	47.75%	39.60%	45.88%	45.94%
EBITDA Margin	93.09%	-73.05%	57.61%	116.47%	61.34%	9.26%	139.67%	36.00%	41.80%	70.59%
Operating Margin	14.61%	-49.86%	11.03%	8.27%	37.34%	67.54%	13.00%	3.25%	18.12%	109.53%
EBIT Margin	63.13%	-137.46%	24.36%	86.35%	37.83%	-21.29%	107.33%	3.69%	7.84%	52.82%
Profit (Net Income) Margin	15.54%	56.48%	-23.62%	32.60%	-44.58%	-154.99%	31.42%	-42.41%	-52.39%	25.71%
Tax Burden Percent	62.93%	74.10%	88.04%	82.12%	76.49%	84.89%	58.54%	80.37%	86.19%	87.93%
Interest Burden Percent	39.10%	-55.45%	-110.14%	45.97%	-154.04%	857.72%	50.00%	-1,430.95%	-775.00%	55.35%
Effective Tax Rate	37.07%	25.90%	0.00%	17.88%	0.00%	0.00%	41.46%	0.00%	0.00%	12.07%
Return on Invested Capital (ROIC)	1.63%	-4.12%	1.09%	0.91%	3.56%	5.52%	0.50%	0.14%	0.72%	11.53%
ROIC Less NNEP Spread (ROIC-NNEP)	1.97%	-1.91%	-0.24%	2.23%	-0.03%	-5.05%	1.50%	-1.74%	-2.30%	7.12%
Return on Net Nonoperating Assets (RNNOA)	3.01%	-2.94%	-0.34%	3.03%	-0.04%	-7.72%	2.27%	-2.42%	-3.41%	11.28%
Return on Equity (ROE)	4.64%	-7.06%	0.75%	3.95%	3.52%	-2.20%	2.77%	-2.28%	-2.69%	22.81%
Cash Return on Invested Capital (CROIC)	-0.91%	-1.39%	-0.55%	6.04%	5.46%	6.93%	6.41%	3.74%	2.37%	16.06%
Operating Return on Assets (OROA)	6.75%	-9.19%	2.07%	6.97%	3.11%	-1.50%	4.18%	0.13%	0.27%	3.83%
Return on Assets (ROA)	1.66%	3.78%	-2.00%	2.63%	-3.67%	-10.91%	1.22%	-1.50%	-1.78%	1.86%
Return on Common Equity (ROCE)	3.49%	-5.28%	0.51%	2.58%	2.25%	-1.35%	1.69%	-1.31%	-1.48%	11.80%
Return on Equity Simple (ROE_SIMPLE)	5.55%	0.00%	1.72%	3.78%	-0.31%	0.00%	-12.34%	-18.60%	-19.42%	0.00%
Net Operating Profit after Tax (NOPAT)	14	-26	9.38	9.85	38	72	9.13	2.59	16	164
NOPAT Margin	9.20%	-36.94%	7.72%	6.79%	26.14%	47.28%	7.61%	2.27%	12.68%	96.31%
Net Nonoperating Expense Percent (NNEP)	-0.33%	-2.21%	1.32%	-1.31%	3.59%	10.57%	-1.01%	1.88%	3.02%	4.41%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.34%	-	-	-	1.01%	-	-	-	2.55%
Cost of Revenue to Revenue	53.32%	246.97%	48.31%	58.86%	55.15%	69.97%	52.25%	60.40%	54.12%	54.06%
SG&A Expenses to Revenue	6.06%	15.42%	6.91%	6.00%	5.84%	6.70%	6.92%	8.34%	8.00%	6.35%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.06%	-97.12%	40.66%	32.87%	7.51%	-37.52%	34.75%	36.35%	27.76%	-63.59%
Earnings before Interest and Taxes (EBIT)	96	-95	30	125	54	-32	129	4.20	10	90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	141	-51	70	169	88	14	168	41	53	120
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.41	1.39	1.57	1.54	1.57	1.67	0.00	1.52	1.84	1.69
Price to Tangible Book Value (P/TBV)	1.41	1.39	1.57	1.54	1.57	1.67	0.00	1.52	1.84	1.69
Price to Revenue (P/Rev)	2.22	3.52	3.03	3.16	2.90	2.87	0.00	4.82	5.82	2.58
Price to Earnings (P/E)	23.62	29.35	0.00	56.59	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	7.03%	6.96%	6.35%	6.36%	7.00%	8.28%	11.33%	8.64%	6.52%	6.01%
Earnings Yield	4.23%	3.41%	0.00%	1.77%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.11	1.11	1.15	1.15	1.15	1.14	0.00	1.10	1.16	1.13
Enterprise Value to Revenue (EV/Rev)	6.45	10.09	8.28	8.36	8.25	9.54	0.00	17.92	19.79	8.89
Enterprise Value to EBITDA (EV/EBITDA)	8.78	16.54	13.08	10.96	11.94	15.72	0.00	85.48	222.44	12.37
Enterprise Value to EBIT (EV/EBIT)	12.17	35.62	21.71	16.68	18.58	30.33	0.00	0.00	0.00	20.28
Enterprise Value to NOPAT (EV/NOPAT)	22.48	63.18	86.20	90.02	65.10	42.13	0.00	0.00	0.00	29.51
Enterprise Value to Operating Cash Flow (EV/OCF)	110.03	165.66	229.57	106.88	155.64	109.70	0.00	60.35	66.93	85.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	18.65	20.59	16.07	0.00	28.42	47.36	6.63
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.84	2.78	2.83	2.42	2.56	2.95	2.98	3.05	3.17	2.92
Long-Term Debt to Equity	2.84	2.78	2.83	2.42	2.56	2.95	2.98	3.05	3.17	2.92
Financial Leverage	1.53	1.54	1.43	1.36	1.42	1.53	1.51	1.39	1.48	1.58
Leverage Ratio	4.20	4.23	4.02	3.94	4.00	4.20	4.21	4.01	4.14	4.27
Compound Leverage Factor	1.64	-2.35	-4.43	1.81	-6.17	35.99	2.11	-57.40	-32.12	2.36
Debt to Total Capital	73.99%	73.54%	73.91%	70.80%	71.90%	74.66%	74.87%	75.33%	76.00%	74.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	73.99%	73.54%	73.91%	70.80%	71.90%	74.66%	74.87%	75.33%	76.00%	74.52%
Preferred Equity to Total Capital	7.93%	7.80%	7.84%	10.49%	10.82%	11.13%	11.12%	11.40%	11.47%	12.30%
Noncontrolling Interests to Total Capital	0.22%	0.61%	0.62%	0.61%	0.60%	0.61%	0.60%	0.59%	0.57%	0.54%
Common Equity to Total Capital	17.86%	18.05%	17.63%	18.10%	16.68%	13.60%	13.41%	12.69%	11.96%	12.64%
Debt to EBITDA	8.87	16.95	12.83	10.50	11.54	15.52	28.57	89.87	225.57	12.53
Net Debt to EBITDA	4.78	8.83	6.82	5.17	5.91	8.54	14.59	48.18	121.26	6.61
Long-Term Debt to EBITDA	8.87	16.95	12.83	10.50	11.54	15.52	28.57	89.87	225.57	12.53
Debt to NOPAT	22.73	64.77	84.57	86.24	62.93	41.61	-38.70	-36.46	-31.79	29.90
Net Debt to NOPAT	12.24	33.73	44.95	42.46	32.21	22.89	-19.76	-19.54	-17.09	15.78
Long-Term Debt to NOPAT	22.73	64.77	84.57	86.24	62.93	41.61	-38.70	-36.46	-31.79	29.90
Altman Z-Score	0.33	0.20	0.28	0.32	0.25	0.12	0.00	0.07	0.08	0.13
Noncontrolling Interest Sharing Ratio	24.83%	25.18%	31.18%	34.70%	36.13%	38.65%	39.17%	42.64%	44.89%	48.27%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.75	0.71	0.66	0.65	0.62	0.60	1.01	0.72	0.73	0.47
Quick Ratio	0.75	0.71	0.66	0.65	0.62	0.60	1.01	0.72	0.73	0.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-273	-179	-83	247	218	278	449	321	290	716
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	105.46%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-209.79	-0.94	0.00	145.03	3.40	1.43	0.00	641.18	4.31	3.67
Operating Cash Flow to Interest Expense	12.92	0.20	0.00	38.06	-0.01	0.26	0.00	73.40	-0.08	0.15
Operating Cash Flow Less CapEx to Interest Expense	86.46	0.23	0.00	42.71	0.86	0.42	0.00	3.80	1.48	0.72
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.07	0.08	0.08	0.08	0.07	0.04	0.04	0.03	0.07
Accounts Receivable Turnover	20.86	14.04	17.09	16.19	15.40	11.47	7.35	6.81	5.77	11.07
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.17	0.11	0.14	0.13	0.13	0.11	0.06	0.06	0.06	0.12
Accounts Payable Turnover	21.13	18.45	26.91	23.67	31.71	19.35	23.43	22.42	25.80	20.38
Days Sales Outstanding (DSO)	17.50	25.99	21.35	22.54	23.71	31.82	49.67	53.61	63.26	32.97
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	17.27	19.79	13.56	15.42	11.51	18.86	15.58	16.28	14.15	17.91
Cash Conversion Cycle (CCC)	0.23	6.20	7.79	7.12	12.20	12.96	34.09	37.33	49.11	15.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,920	4,920	4,941	4,827	4,740	4,714	4,501	4,509	4,466	4,161
Invested Capital Turnover	0.18	0.11	0.14	0.13	0.14	0.12	0.07	0.06	0.06	0.12
Increase / (Decrease) in Invested Capital	287	154	93	-237	-180	-206	-440	-318	-274	-553
Enterprise Value (EV)	5,469	5,450	5,693	5,568	5,432	5,364	0.00	4,967	5,161	4,722
Market Capitalization	1,882	1,902	2,085	2,105	1,910	1,616	0.00	1,337	1,518	1,373
Book Value per Share	$9.68	$9.95	$9.66	$9.78	$8.74	$6.92	$6.88	$6.40	$6.00	$5.91
Tangible Book Value per Share	$9.68	$9.95	$9.66	$9.78	$8.74	$6.92	$6.88	$6.40	$6.00	$5.91
Total Capital	7,471	7,597	7,557	7,535	7,303	7,096	7,102	6,932	6,886	6,421
Total Debt	5,527	5,587	5,586	5,335	5,251	5,298	5,317	5,222	5,233	4,785
Total Long-Term Debt	5,527	5,587	5,586	5,335	5,251	5,298	5,317	5,222	5,233	4,785
Net Debt	2,977	2,910	2,969	2,627	2,687	2,915	2,716	2,799	2,813	2,525
Capital Expenditures (CapEx)	-96	-6.60	-73	-7.90	-56	-31	-277	35	-105	-111
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-576	-634	-551	-619	-560	-558	-536	-522	-515	-502
Debt-free Net Working Capital (DFNWC)	-156	-194	-202	-232	-229	-245	6.10	-156	-148	-284
Net Working Capital (NWC)	-156	-194	-202	-232	-229	-245	6.10	-156	-148	-284
Net Nonoperating Expense (NNE)	-9.63	-65	38	-37	102	308	-29	51	83	120
Net Nonoperating Obligations (NNO)	2,977	2,910	2,969	2,627	2,687	2,915	2,716	2,799	2,813	2,525
Total Depreciation and Amortization (D&A)	46	45	40	44	34	47	39	37	43	30
Debt-free, Cash-free Net Working Capital to Revenue	-67.91%	-117.33%	-80.13%	-92.84%	-85.03%	-99.25%	-173.79%	-188.38%	-197.55%	-94.37%
Debt-free Net Working Capital to Revenue	-18.34%	-35.98%	-29.36%	-34.76%	-34.76%	-43.49%	1.98%	-56.12%	-56.79%	-53.44%
Net Working Capital to Revenue	-18.34%	-35.98%	-29.36%	-34.76%	-34.76%	-43.49%	1.98%	-56.12%	-56.79%	-53.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.12	$0.17	($0.30)	$0.28	($0.66)	($1.78)	$0.19	($0.43)	($0.56)	$0.24
Adjusted Weighted Average Basic Shares Outstanding	136.84M	136.90M	137.95M	139.39M	139.39M	138.93M	138.47M	137.59M	137.41M	137.78M
Adjusted Diluted Earnings per Share	$0.12	$0.18	($0.30)	$0.28	($0.66)	($1.78)	$0.19	($0.43)	($0.56)	$0.24
Adjusted Weighted Average Diluted Shares Outstanding	137.08M	138.57M	137.95M	139.55M	139.39M	138.93M	138.63M	137.59M	137.41M	137.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	137.79M	137.97M	139.39M	139.39M	139.39M	138.98M	137.53M	137.41M	137.41M	138.01M
Normalized Net Operating Profit after Tax (NOPAT)	14	-26	9.38	9.85	16	72	9.13	2.59	12	164
Normalized NOPAT Margin	9.20%	-36.94%	7.72%	6.79%	11.34%	47.28%	7.61%	2.27%	9.28%	96.31%
Pre Tax Income Margin	24.69%	76.22%	-26.83%	39.70%	-58.28%	-182.59%	53.67%	-52.77%	-60.78%	29.24%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	73.77	-0.50	0.00	73.71	0.85	-0.17	0.00	8.40	0.15	0.46
NOPAT to Interest Expense	10.75	-0.13	0.00	5.80	0.59	0.37	0.00	5.18	0.24	0.84
EBIT Less CapEx to Interest Expense	147.31	-0.47	0.00	78.35	1.71	-0.01	0.00	-61.20	1.71	1.03
NOPAT Less CapEx to Interest Expense	84.29	-0.10	0.00	10.44	1.45	0.53	0.00	-64.42	1.80	1.41
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	165.42%	168.11%	539.16%	225.31%	-3,060.32%	-70.79%	-91.40%	-64.23%	-53.50%	-445.70%
Augmented Payout Ratio	230.28%	198.72%	579.82%	241.89%	-3,261.90%	-78.22%	-99.12%	-71.41%	-60.68%	-490.21%

Frequently Asked Questions About Kennedy-Wilson's Financials

When does Kennedy-Wilson's financial year end?

According to the most recent income statement we have on file, Kennedy-Wilson's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Kennedy-Wilson's net income changed over the last 10 years?

Kennedy-Wilson's net income appears to be on a downward trend, with a most recent value of -$33.70 million in 2024, falling from $90.10 million in 2014. The previous period was -$281.40 million in 2023. Check out Kennedy-Wilson's forecast to explore projected trends and price targets.

What is Kennedy-Wilson's operating income?

Kennedy-Wilson's total operating income in 2024 was $228.60 million, based on the following breakdown:

Total Gross Profit: $239 million
Total Operating Expenses: $10.40 million

How has Kennedy-Wilson revenue changed over the last 10 years?

Over the last 10 years, Kennedy-Wilson's total revenue changed from $398.60 million in 2014 to $531.40 million in 2024, a change of 33.3%.

How much debt does Kennedy-Wilson have?

Kennedy-Wilson's total liabilities were at $5.33 billion at the end of 2024, a 10.0% decrease from 2023, and a 61.9% increase since 2014.

How much cash does Kennedy-Wilson have?

In the past 10 years, Kennedy-Wilson's cash and equivalents has ranged from $174.60 million in 2014 to $965.10 million in 2020, and is currently $217.50 million as of their latest financial filing in 2024.

How has Kennedy-Wilson's book value per share changed over the last 10 years?

Over the last 10 years, Kennedy-Wilson's book value per share changed from 9.50 in 2014 to 5.91 in 2024, a change of -37.9%.

Related Companies

This page (NYSE:KW) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kennedy-Wilson (KW) Financials

Frequently Asked Questions About Kennedy-Wilson's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kennedy-Wilson (KW) Financials

Annual Income Statements for Kennedy-Wilson

Quarterly Income Statements for Kennedy-Wilson

Annual Cash Flow Statements for Kennedy-Wilson

Quarterly Cash Flow Statements for Kennedy-Wilson

Annual Balance Sheets for Kennedy-Wilson

Quarterly Balance Sheets for Kennedy-Wilson

Annual Metrics and Ratios for Kennedy-Wilson

Quarterly Metrics and Ratios for Kennedy-Wilson

Frequently Asked Questions About Kennedy-Wilson's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools